This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.
A contagious infection produces a structural lung problem
The virus infects cells in the lung and drives tumor formation. As affected tissue expands, breathing becomes more difficult. This is why OPA is more than a recurrent bacterial chest infection: an antimicrobial may address a secondary complication but cannot remove the tumor. Disease mechanism and clinical care.
The long interval before visible illness complicates flock control. A sheep may look normal while infected, and clinical cases can be only a fraction of the infected population. Purchasing an outwardly healthy animal therefore does not provide the same assurance as a supported source-flock assessment. Silent infection and introduction risk.
The word “cancer” does not mean it behaves like every noninfectious tumor. Transmission between sheep is relevant, so an individual welfare problem also creates a flock-management question.
Recognize worsening breathing before a sheep is exhausted
Progressive loss of condition, increased breathing effort and an animal falling behind the group are important signs. Clear or frothy nasal fluid can be striking, but some affected sheep do not produce obvious fluid. Its absence cannot exclude OPA. Secondary bacterial disease can alter the presentation and speed deterioration.
Observe at rest rather than forcing exercise to reveal signs. A sheep struggling to breathe should be handled quietly and assessed promptly. Do not lift its hindquarters or force its head down to produce nasal fluid; that maneuver can cause considerable distress and is unnecessary as a farm demonstration. Clinical signs and welfare limitations of provocative examination.
Severe dyspnea or inability to eat and move comfortably calls for an urgent welfare decision. Waiting until an animal collapses is not an appropriate way to confirm a chronic diagnosis.
Other chronic diseases can look similar
Maedi-visna, caseous lymphadenitis, lung abscesses, parasitic disease and other causes of wasting may enter the differential. OPA can also coexist with other lung disease. A response to treatment of secondary infection does not necessarily exclude an underlying tumor.
The veterinarian combines the respiratory examination with body condition, age, flock context and appropriate investigation. A characteristic appearance can guide suspicion, but it should not replace a diagnosis when flock-control decisions depend on the result.
Ultrasound looks for lesions rather than certifying every infection
Transthoracic ultrasound can identify suitable lung-surface lesions, including some before clinical signs develop. It is useful for veterinary flock screening, but its ability to find disease depends on lesion size, location, stage and the examination. A negative result means no detectable lesion was identified by that examination; it is not proof that the sheep carries no virus. Interpreting a negative OPA ultrasound screen.
Nor is there a simple routine individual blood test that reliably identifies every sheep before tumor development. A laboratory or imaging method should be judged by the clinical question it can answer, rather than assumed to be a universal certificate of freedom. Current diagnostic limitations.
Professional postmortem examination and pathology can confirm the diagnosis and assess concurrent disease. Arranging that examination after a suspect case is removed may be more useful than treating repeated unexplained wasting as an inevitable part of the flock.
The affected sheep needs a realistic prognosis
No treatment reverses OPA. Veterinary care focuses on confirming the problem and preventing prolonged respiratory suffering. Affected sheep should be removed appropriately from the flock, with the method determined by welfare, clinical condition and applicable rules. A severely compromised animal may require euthanasia rather than transport.
Antimicrobials can produce temporary improvement when bacterial complications are present. That improvement should not be mistaken for cure of the cancer or a reason to return a confirmed case to normal breeding management. Treatment and control limitations.
Discuss the fate of dependent lambs and how their care fits the flock plan. Keep animal welfare and transmission considerations together instead of assuming that an apparently vigorous offspring provides assurance about infection status.
Control needs more than removing the visibly breathless sheep
Screen-and-remove strategies using veterinary ultrasound can reduce detectable disease, but repeated assessment may be needed because early infection can be missed. Ask the veterinarian how often screening is justified and what result should trigger removal or further examination. Avoid promising that one flock scan eradicates the infection.
Limit opportunities for close respiratory exposure between infected and susceptible groups where practical. Consider age grouping and replacement sourcing, and investigate unexplained thin sheep rather than retaining them until the next routine cull. A short quarantine without signs is limited protection against a disease that may remain silent for a long time. Purchase and quarantine limitations.
There is no routine vaccine that can simply replace these measures. The appropriate plan depends on whether the goal is to keep infection out or reduce losses in an affected flock.
Is every sheep with a wet nose affected?
No. Nasal discharge has many causes. Persistent respiratory effort and wasting warrant investigation, while characteristic fluid strengthens concern without being required in every case.
Is OPA the same as the contagious nasal tumor?
No. Enzootic nasal adenocarcinoma affects the upper airway and involves a related but different viral disease. Continue through the sheep hub for other chronic respiratory conditions.
Cite this reference
LivestockDefense. “Ovine pulmonary adenocarcinoma: jaagsiekte, breathing difficulty and flock control.” Updated 2026-11-02. https://livestockdefense.com/threats/ovine-pulmonary-adenocarcinoma/
Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.
How to cite a page and its revision ↗Sources & boundaries
Read the evidence in context.
These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.
- Merck Veterinary Manual: Ovine pulmonary adenocarcinoma
Source update: 2025-04. Most recent check: 2026-11-02.
Infectious lung tumor, progressive dyspnea/wasting, clinical differential, imaging and absence of curative treatment. Distressing wheelbarrow maneuver and all agent-production procedures explicitly not reproduced.
- Moredun Research Institute: Ovine pulmonary adenocarcinoma
Source update: Not provided. Most recent check: 2026-11-02.
Silent infection, transmission, clinical fluid not present in all cases, ultrasound use and absence of reliable individual pre-tumor certification. Historical research projects not described as current clinical availability.
- Moredun Research Institute: Biosecurity: ovine pulmonary adenocarcinoma
Source update: 2023. Most recent check: 2026-11-02.
OPA section: purchase risk, screening visible lesions versus infection and negative ultrasound limitations. No blanket diagnostic sensitivity or guaranteed quarantine interval.
